8-K: Cognizant Reaches Settlement in Stockholder Derivative Lawsuit

Cognizant Technology Solutions Corporation announced preliminary approval of a settlement in a stockholder derivative action, resolving claims related to alleged FCPA violations and share repurchases.

Summary

• Cognizant Technology Solutions Corporation has received preliminary approval for a settlement in a stockholder derivative lawsuit.
• The lawsuit, captioned Viswanatha Palempalli v. Michael Pastalos-Fox, et al., alleged breaches of fiduciary duty, waste of corporate assets, unjust enrichment, and violations of securities laws.
• The core allegations involved the company's alleged violation of the Foreign Corrupt Practices Act (FCPA) and share repurchases at excessive prices.
• As part of the settlement, Cognizant's directors and officers insurance carriers will pay $5.5 million to Cognizant.
• Plaintiff's counsel will seek court approval for attorneys' fees and expenses not exceeding $1,830,000, and a service award of up to $15,000 for the plaintiff.
• A final settlement hearing is scheduled for September 14, 2026, to determine final court approval.
• The settlement resolves claims against current and former officers and directors, with both parties denying any wrongdoing.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as it resolves a significant legal overhang for Cognizant, although the underlying allegations were serious.

Positives

• The company has reached a settlement in a significant stockholder derivative lawsuit, potentially resolving a long-standing legal matter.
• The settlement involves a $5.5 million payment from insurance carriers, which will benefit Cognizant.
• The settlement aims to avoid further litigation costs and disruption for the company.
• The court has granted preliminary approval, indicating the settlement is considered fair and reasonable at this stage.

Negatives

• The lawsuit involved serious allegations of FCPA violations and waste of corporate assets.
• The settlement requires a payment of $5.5 million, although this is covered by insurance.
• Plaintiff's counsel is seeking up to $1.83 million in fees and expenses, which will be deducted from the settlement amount paid to Cognizant.

Risks

• The settlement is subject to final court approval at the hearing on September 14, 2026.
• There is a risk that the court may not approve the settlement or the requested attorneys' fees and expenses.
• While the settlement aims to resolve claims, the underlying allegations of FCPA violations and improper share repurchases could have reputational implications if not fully addressed.

Future Outlook

The company is awaiting final court approval for the settlement of the stockholder derivative action, with a hearing scheduled for September 14, 2026. If approved, the settlement will resolve the claims and result in a payment to Cognizant from its insurers.

Management Comments

• Defendants dispute the allegations, expressly deny all alleged wrongdoing and contentions that Cognizant suffered injury or damages as a result of any alleged misconduct, and maintain that they complied with all applicable legal duties and acted in good faith and in the bests interests of Cognizant and its stockholders at all times.
• Defendants have denied and continue to deny all of the claims alleged by Plaintiff in the Derivative Action, including that the Board wrongfully refused the Demand.
• Each of Defendants expressly denies and continues to deny any and all allegations of wrongdoing or liability against himself/herself/themselves or itself arising out of, based upon, related to, or in connection with any conduct, statements, acts, or omissions alleged, which could have been alleged, or which could in the future be alleged in the Derivative Action.
• Cognizant has approved the Settlement as set forth in the Stipulation as serving the best interests of the Company and its stockholders and agrees that the Settlement confers a substantial benefit and is fair, reasonable, and adequate.

Industry Context

StockSavvy.ai notes that settlements in derivative lawsuits are common in the technology sector, particularly when allegations involve compliance issues like FCPA violations or financial improprieties. The structure of this settlement, with payment from D&O insurance carriers, is a typical mechanism to resolve such disputes without direct financial impact on the company's operating capital.

Legal Proceedings

• Stockholder derivative action captioned Viswanatha Palempalli v. Michael Pastalos-Fox, et al., No. 2:21-cv-12025-EP-SDA, alleging breach of fiduciary duty, waste of corporate assets, unjust enrichment, and violations of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5.
• Allegations include violations of the Foreign Corrupt Practices Act (FCPA) and share repurchases at excessive prices.
• Related securities class action captioned In re Cognizant Tech. Sols. Corp. Sec. Litig., No. 2:16-cv-06509-ES-CLW, which Cognizant settled for $95 million.

Stakeholder Impact

• Shareholders: The settlement provides a financial benefit to Cognizant through the insurance payout, potentially increasing shareholder value. However, the settlement amount is less than the initial securities class action settlement.
• Management/Directors: The settlement resolves claims against current and former officers and directors, providing them with release from liability related to the derivative action, though the payment comes from their D&O insurance.
• Insurers: The D&O insurance carriers will pay $5.5 million to Cognizant as part of the settlement.

Next Steps

• A Settlement Hearing will be held on September 14, 2026, for the Court to determine final approval of the settlement.
• Stockholders have until August 31, 2026, to file any objections to the settlement.

Key Dates

Recommendation

The filing primarily concerns the resolution of a past legal matter through a settlement. While it removes a legal overhang and provides a modest financial benefit via insurance, it does not contain new operational or strategic information that would warrant a change in investment recommendation. The focus remains on the company's ongoing business performance and future prospects.

Keywords

Cognizant Technology Solutions, SEC Filing, Form 8-K, Stockholder Derivative Action, Settlement, FCPA, Breach of Fiduciary Duty, Securities Litigation, Directors and Officers Insurance